RANOLAZINE
Active substance: ranolazine
TABLET, FILM COATED, EXTENDED RELEASE · RANOLAZINE 1000 mg/1
United StatesActive
Marketing holder: A2A Integrated Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- RANOLAZINE · 1000 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2ea6-73ff-a964-ccc41b7af2d6,01a1208c-4de7-7f8f-b9f5-b15a2644c95c,01a1208c-62b5-76b0-b075-32a2c23fb843,01a1208c-6a9f-75d2-b1a6-a6ba78d683db,01a1208c-cfe6-792b-b80f-400bd1e67001;count=55 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73141-022
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 73141-022 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73141-022 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73141-022 · Verified 2026-10-09 · open in source